Aardvark Therapeutics Announces $94.2 Million IPO
February 14, 2025
February 14, 2025
PALO ALTO, California, Feb. 14 -- Cooley, a law firm, issued the following news release:
* * *
Aardvark Therapeutics Announces $94.2 Million IPO
San Diego - February 14, 2025 - Cooley advised the underwriters of Aardvark Therapeutics, a phase 3 biotech company developing novel small-molecule therapies for metabolic diseases, in connection with Aardvark's $94.2 million initial public offering (IPO).
Aardvark offered 5,888,000 shares priced . . .
* * *
Aardvark Therapeutics Announces $94.2 Million IPO
San Diego - February 14, 2025 - Cooley advised the underwriters of Aardvark Therapeutics, a phase 3 biotech company developing novel small-molecule therapies for metabolic diseases, in connection with Aardvark's $94.2 million initial public offering (IPO).
Aardvark offered 5,888,000 shares priced . . .